NO20064661L - Oyenlosning som innbefatter natriumkarboksymetylcellulose og hydroksypropylmetylcellulose - Google Patents

Oyenlosning som innbefatter natriumkarboksymetylcellulose og hydroksypropylmetylcellulose

Info

Publication number: NO20064661L
Authority: NO; Norway
Prior art keywords: cellulose; sodium carboxymethyl; hydroxypropyl methyl; solution including; including sodium
Prior art date: 2004-03-17

Application number

NO20064661A

Other languages

English (en)

Norwegian (no)

Inventor

Fu-Pao Tsao

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-17

Filing date

2006-10-13

Publication date

2006-12-14

2006-10-13 Application filed by Novartis Ag filed Critical Novartis Ag

2006-12-14 Publication of NO20064661L publication Critical patent/NO20064661L/no

Links

239000001866 hydroxypropyl methyl cellulose Substances 0.000 title abstract 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title abstract 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title abstract 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 title abstract 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 title 1
239000001768 carboxy methyl cellulose Substances 0.000 title 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 title 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 title 1
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 6
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000002335 preservative effect Effects 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

NO20064661A 2004-03-17 2006-10-13 Oyenlosning som innbefatter natriumkarboksymetylcellulose og hydroksypropylmetylcellulose NO20064661L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55388004P	2004-03-17	2004-03-17
PCT/EP2005/002804 WO2005089715A1 (fr)	2004-03-17	2005-03-16	Solution ophtalmique comprenant une carboxymethylecellulose de sodium et une hydroxypropylmethylocellulose

Publications (1)

Publication Number	Publication Date
NO20064661L true NO20064661L (no)	2006-12-14

Family

ID=34962605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064661A NO20064661L (no)	2004-03-17	2006-10-13	Oyenlosning som innbefatter natriumkarboksymetylcellulose og hydroksypropylmetylcellulose

Country Status (15)

Country	Link
US (4)	US20050244509A1 (fr)
EP (1)	EP1732511A1 (fr)
JP (1)	JP2007529458A (fr)
KR (1)	KR20070005625A (fr)
CN (1)	CN1933812A (fr)
AU (1)	AU2005224012B2 (fr)
BR (1)	BRPI0508858A (fr)
CA (1)	CA2557795A1 (fr)
EC (1)	ECSP066808A (fr)
IL (1)	IL177725A0 (fr)
MA (1)	MA28507B1 (fr)
NO (1)	NO20064661L (fr)
RU (1)	RU2006136092A (fr)
TN (1)	TNSN06293A1 (fr)
WO (1)	WO2005089715A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070048389A1 (en) *	2005-08-26	2007-03-01	Fu-Pao Tsao	Stabilized and preserved ketotifen ophthalmic compositions
US20070048388A1 (en) *	2005-08-26	2007-03-01	Fu-Pao Tsao	Stabilized and preserved ketotifen ophthalmic compositions
AR059927A1 (es)	2006-03-17	2008-05-07	Johnson & Johnson Vision Care	Metodos para la estabilizacion de composiciones inestables a la oxidacion y composiciones oftalmicas estabilizadas
US20070264226A1 (en) *	2006-05-10	2007-11-15	Karagoezian Hampar L	Synergistically enhanced disinfecting solutions
AU2013224663B2 (en) *	2007-08-31	2015-01-15	Alcon Inc.	Contact Lens Products
TWI551305B (zh) *	2007-08-31	2016-10-01	諾華公司	相對黏稠封裝溶液之用途
US20090239954A1 (en) *	2008-03-19	2009-09-24	Collins Gary L	Phosphate buffered ophthalmic solutions displaying improved efficacy
TW201127423A (en)	2009-12-17	2011-08-16	Alcon Res Ltd	Ophthalmic solutions with improved disinfection profiles
US20150000936A1 (en) *	2011-12-13	2015-01-01	Schlumberger Technology Corporation	Energization of an element with a thermally expandable material
US9829723B2 (en)	2015-12-03	2017-11-28	Novartis Ag	Contact lens packaging solutions
US11185487B2 (en)	2015-12-28	2021-11-30	Johnson & Johnson Consumer Inc.	Hair growth composition and method
CN107041892B (zh) *	2016-07-12	2021-02-26	合肥九研医药科技开发有限公司	羟丙基甲基纤维素在上消化道黏膜损伤护理上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4880601A (en) *	1985-09-27	1989-11-14	Laboratoires, P.O.S.	Hydrogen peroxide disinfecting system for contact lenses
US5607698A (en) *	1988-08-04	1997-03-04	Ciba-Geigy Corporation	Method of preserving ophthalmic solution and compositions therefor
US5888493A (en) *	1996-12-05	1999-03-30	Sawaya; Assad S.	Ophthalmic aqueous gel formulation and related methods
EP1324782B1 (fr) *	2000-09-28	2004-08-11	Novartis AG	Solutions ophthalmiques stabilisees de peroxyde d'hydrogene
AR038299A1 (es) *	2002-01-18	2005-01-12	Novartis Ag	Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas.

2005
- 2005-03-11 US US11/078,209 patent/US20050244509A1/en not_active Abandoned
- 2005-03-16 CN CNA2005800084792A patent/CN1933812A/zh active Pending
- 2005-03-16 BR BRPI0508858-5A patent/BRPI0508858A/pt not_active IP Right Cessation
- 2005-03-16 JP JP2007503283A patent/JP2007529458A/ja active Pending
- 2005-03-16 EP EP05716123A patent/EP1732511A1/fr not_active Withdrawn
- 2005-03-16 CA CA002557795A patent/CA2557795A1/fr not_active Abandoned
- 2005-03-16 RU RU2006136092/15A patent/RU2006136092A/ru unknown
- 2005-03-16 WO PCT/EP2005/002804 patent/WO2005089715A1/fr not_active Ceased
- 2005-03-16 KR KR1020067018918A patent/KR20070005625A/ko not_active Withdrawn
- 2005-03-16 AU AU2005224012A patent/AU2005224012B2/en not_active Ceased
2006
- 2006-08-28 IL IL177725A patent/IL177725A0/en unknown
- 2006-08-30 EC EC2006006808A patent/ECSP066808A/es unknown
- 2006-09-15 TN TNP2006000293A patent/TNSN06293A1/en unknown
- 2006-09-27 MA MA29348A patent/MA28507B1/fr unknown
- 2006-10-13 NO NO20064661A patent/NO20064661L/no not_active Application Discontinuation
2007
- 2007-12-20 US US11/961,034 patent/US20080096978A1/en not_active Abandoned
2010
- 2010-02-19 US US12/708,749 patent/US20100143493A1/en not_active Abandoned
2012
- 2012-05-07 US US13/465,225 patent/US20120220961A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ECSP066808A (es)	2006-11-16
IL177725A0 (en)	2006-12-31
BRPI0508858A (pt)	2007-08-28
AU2005224012B2 (en)	2009-07-02
TNSN06293A1 (en)	2007-12-03
US20050244509A1 (en)	2005-11-03
WO2005089715A1 (fr)	2005-09-29
MA28507B1 (fr)	2007-04-03
RU2006136092A (ru)	2008-04-27
EP1732511A1 (fr)	2006-12-20
US20080096978A1 (en)	2008-04-24
AU2005224012A1 (en)	2005-09-29
US20100143493A1 (en)	2010-06-10
JP2007529458A (ja)	2007-10-25
KR20070005625A (ko)	2007-01-10
CN1933812A (zh)	2007-03-21
US20120220961A1 (en)	2012-08-30
CA2557795A1 (fr)	2005-09-29

Legal Events

Date	Code	Title	Description
2011-10-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20064661L (no)	2006-12-14	Oyenlosning som innbefatter natriumkarboksymetylcellulose og hydroksypropylmetylcellulose
NO20045072L (no)	2005-01-20	Tablett med hoyt medikamentinnhold
AR061495A1 (es)	2008-09-03	Composiciones detergentes
BR112022019073A2 (pt)	2022-11-08	Composição farmacêutica que compreende conjugado anticorpo-fármaco e uso da mesma
AR072329A2 (es)	2010-08-25	Composicion farmaceutica que comprende nateglinida
WO2007131088A3 (fr)	2008-01-17	Compositions pour réhydratation orale
NO20082384L (no)	2008-05-26	Preparat, omfattende jern(III) komplekssammensetninger og redoxaktive substans(er)
BR0314269A (pt)	2005-07-26	Cápsulas contendo composições aquosas de recheio estabilizadas com ciclodextrina derivatizada
WO2007090192A3 (fr)	2007-12-13	Composition stable et aqueuse homogene blanchissante de dents
MX2009011554A (es)	2010-01-25	Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
CO6440528A2 (es)	2012-05-15	Composiciones adyuvantes que comprenden un agente de isotonicidad no iónico.
MX2007003162A (es)	2007-05-16	Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa.
NO20080164L (no)	2008-03-14	N-(pyridin-2-yl)-sulfonamidderivater
NO20083104L (no)	2008-09-19	Fast preparat
UA109421C2 (uk)	2015-08-25	Фармацевтична композиція, яка містить ліганди сигма-рецептора
SG155961A1 (en)	2009-10-29	Pyrazoles as 11-beta-hsd-1
PE20120023A1 (es)	2012-02-13	Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
BRPI0517999A (pt)	2008-10-21	derivados de tetraidropirano como antidiabéticos
MX2010003488A (es)	2010-08-31	Composiciones de oftalmologia basadas en polisacarido y acido hialuronico de semillas de tamarindo.
JP2010520246A5 (fr)	2011-04-21
TW200744617A (en)	2007-12-16	Agent increasing the production of thioredoxin
AR110174A2 (es)	2019-03-06	Agentes endoparasiticidas y procedimiento de preparación
UA101407C2 (ru)	2013-03-25	Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
DK1377164T3 (da)	2008-10-13	Erythropoietin forbedrer kemoterapi-induceret toksicitet in vivo
NO20060208L (no)	2006-01-13	Farmasoytisk preparat